Coronavirus vaccines - Brighton Biotech

Drug Profile

Coronavirus vaccines - Brighton Biotech

Alternative Names: MERS-CoV vaccine - Brighton; Middle east respiratory syndrome - Brighton; SARS-CoV vaccine - Brighton; Severe acute respiratory syndrome - Brighton

Latest Information Update: 28 Oct 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Baylor College of Medicine; Sabin Vaccine Institute; Texas Children's Hospital Center for Vaccine Development
  • Developer Baylor College of Medicine; Sabin Vaccine Institute
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Middle East respiratory syndrome coronavirus; Severe acute respiratory syndrome

Most Recent Events

  • 20 Oct 2015 Brighton Biotech acquires Coronavirus vaccines from Baylor College of Medicine and Sabin Vaccine Institute
  • 20 Oct 2015 Preclinical trials in Middle East respiratory syndrome coronavirus (Prevention) in USA (unspecified route)
  • 20 Oct 2015 Preclinical trials in Severe acute respiratory syndrome (Prevention) in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top